PDG70 SHORT DURATION OF CONVENTIONAL SYNTHETIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS (CSDMARDS) BEFORE AND AFTER BECOMING A CSDMARD INADEQUATE RESPONDER (IR) IN RHEUMATOID ARTHRITIS (RA) PATIENTS
May 1, 2019, 00:00
10.1016/j.jval.2019.04.749
https://www.valueinhealthjournal.com/article/S1098-3015(19)30941-6/fulltext
Title :
PDG70 SHORT DURATION OF CONVENTIONAL SYNTHETIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS (CSDMARDS) BEFORE AND AFTER BECOMING A CSDMARD INADEQUATE RESPONDER (IR) IN RHEUMATOID ARTHRITIS (RA) PATIENTS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)30941-6&doi=10.1016/j.jval.2019.04.749
First page :
Section Title :
Open access? :
No
Section Order :
10339